Protect Your Investments with Operational Diligence
You back great science and strong teams. Concordia makes sure the operational plan underneath can deliver what the capital depends on.
Every engagement begins with a Portfolio Insight Intensive to evaluate the operational plan, and identify how we can best support you throughout.
Get Full Visibility Into Whether the Plan Can Deliver what the Science Promises.
Clinical execution risk is difficult to evaluate from the outside. Sure, timelines look credible and the CRO’s plans are assembled. But will the assumptions hold when execution begins?
These are the gaps that erode your investment:
Enrollment estimates are often inherited rather than independently validated.
Budget buffers may be thinner than they appear.
CROs are sometimes selected to maintain momentum rather than because the program was fully ready for that model.
And timelines are frequently baked into investor decks before contracts are finalized.
When these happen, burn extends, inflection points shift, and follow-on rounds become stabilization rounds instead of value-creation rounds.
We’ll catch these leaks early so that your funds have more impact in less time.
Add Confidence To Your Portfolio.
Diligence that includes execution reality.
Grounded in actual enrollment behavior and site capacity, not inherited projections that require best-case execution.
Fewer surprises in portfolio reviews.
Assumptions challenged before contracts are signed, not discovered after margin is already committed.
Clearer decisions
Walk into investor and board meetings knowing what's solid, what's being watched, and what you'd do if something shifts.
The Concordia Difference: Risk mitigation with smarter operations.
We’re built for how investors make decisions:
FOUNDER AND PRINCIPAL
Suzanne Vyvoda
Suzanne is a senior clinical operations leader with 20+ years of experience guiding global development programs for emerging biotechs and large pharmaceutical organizations. Her work spans more than 50 countries and 500+ clinical research sites across multiple therapeutic areas and stages of development.
Beginning her career at research sites and CROs, she brings a rare 360° perspective on how decisions flow, where systems break down, and what operational excellence truly requires. Her approach blends strategy, operational design, and real-world execution—helping programs move with clarity, alignment, and control.
WORK WITH US
Start with a Portfolio Insight Intensive
A two-week, senior-level engagement for VCs, operating partners, and investment committees.
Get a rapid, independent view of operational reality before allocating additional capital or signing off on a major commitment. Over two weeks, we review clinical or development programs, vendor relationships, enrollment feasibility, timelines, and execution capabilities to identify risks, misaligned incentives, or gaps that could compromise value creation.
You’ll receive an executive memo detailing high-risk areas, actionable recommendations, capital implications, and a 60-minute walkthrough with investment team.
After your intensive, we offer two right-sized ways to continue working together:
Venture Advisory Retainer
Ongoing strategic access for diligence calls, operational pressure-testing, and executive advising across your clinical-stage portfolio.
Portfolio Acceleration Engagement
Hands-on support embedded within a portfolio company to align clinical strategy with execution — so promising assets move forward on plan.